Corrigendum to 'Co-delivery paclitaxel and IR783 as nanoparticles for potentiated chemo-photothermal-immunotherapy of triple-negative breast cancer' [Mater. Today Bio (2025) 101993].
[This corrects the article DOI: 10.1016/j.mtbio.2025.101993.].
APA
Huang Y, Wang K, et al. (2026). Corrigendum to 'Co-delivery paclitaxel and IR783 as nanoparticles for potentiated chemo-photothermal-immunotherapy of triple-negative breast cancer' [Mater. Today Bio (2025) 101993].. Materials today. Bio, 37, 102067. https://doi.org/10.1016/j.mtbio.2025.102067
MLA
Huang Y, et al.. "Corrigendum to 'Co-delivery paclitaxel and IR783 as nanoparticles for potentiated chemo-photothermal-immunotherapy of triple-negative breast cancer' [Mater. Today Bio (2025) 101993].." Materials today. Bio, vol. 37, 2026, pp. 102067.
PMID
41923984
Abstract
[This corrects the article DOI: 10.1016/j.mtbio.2025.101993.].
같은 제1저자의 인용 많은 논문 (5)
- Improving the performance of the echinococcosis diagnosis model based on serum Raman spectroscopy via the integration of convolutional neural network and support vector machine.
- Construction and application of a nomogram model for early stage central lymph node metastasis in papillary thyroid cancer combined with Hashimoto's thyroiditis.
- A self-sensing vacuole/lysosome: V-ATPase dysfunction activates selective autophagy.
- CHA-driven SERS-nanoenzyme sensor for ultra-sensitive diagnosis of gastric precancerous lesions.
- Unmet supportive care needs of head and neck cancer survivors: A scoping review.